Sage Journals: Discover world-class research

Free access

Research article

First published 2019-12

The Evolving Landscape of Institutional Biosafety Committees and Biosafety Programs: Results from a National Survey on Organizational Structure,Resources,and Practices

Christine M. Johnson, Karen M. Dobos

Applied Biosafety

Free access

Review article

First published 2018-06

Application of the Biosafety RAM and eProtocol Software Programs to Streamline Institutional Biosafety Committee Processes at the USDA-National Animal Disease Center

John P. Bannantine, Karen B. Register, David M. White

Applied Biosafety

Retricted access

Article commentary

First published 2026

Assessing the Importance of Institutional Biosafety Committee Oversight of Clinical Research

Christopher Doyle, Kelly FitzGerald, Sharon Judge [...]

Applied Biosafety

Free access

Research article

First published 2012-03

Current Trends in Institutional Biosafety Committee Practices

Raymond W. Hackney, Theodore A. Myatt, Kathleen M. Gilbert [...]

Applied Biosafety

Free access

Research article

First published 2019-09

So You Want to Start an Institutional Biosafety Committee

Maren Schniederberend, Benjamin Fontes, Rachel Jeffrey

Applied Biosafety

Retricted access

Research article

First published 2008-03

An Evaluation of the Role and Effectiveness of Institutional Biosafety Committees in Providing Oversight and Security at Biocontainment Laboratories

Margaret S. Race, Edward Hammond

Health Security

Free access

Editorial

First published 2009-09

The American Research University and Institutional Biosafety Committees

Kenneth I. Shine, Richard St. Onge

Applied Biosafety

Retricted access

Research article

First published 1984-10

Institutional Biosafety Committees and the Inadequacies of Risk Regulation

Philip L. Bereano

Science,Technology,& Human Values

Free access

Research article

First published 2017-12

Expansion of Northwell Health’s Biosafety Program into the Clinical Setting

Mark Jarrett, Donna Armellino, Michelle Dolojan [...]

Applied Biosafety

Retricted access

Other

First published 2002-4

Comparison of Additional Regulatory Requirements for Conducting Clinical Trials on Genetically-Modified Microorganisms and Recombinant Dna in Europe,the United States,and Canada

King C. Lee

Therapeutic Innovation & Regulatory Science

Search results